Evaluation of amputation risk in diabetic foot ulcer patients infected with Acinetobacter baumannii from a Tertiary Care Centre in South India

Authors

  • Rajesh Kesavan NRA wound care Author
  • Changam Sheela Sasikumar, Sheela Hycare for Wounds Author

DOI:

https://doi.org/10.21276/vpbdz129

Keywords:

Acinetobacter baumannii, Diabetes mellitus, deep tissue cultures, amputation

Abstract

Back ground: Foot complications are found to be a significant frequent, complication of Diabetes mellitus. Carbapenem-resistant Acinetobacter baumannii is gradually becoming dominant among Diabetes patients in urban population. The purpose of this study was to evaluate the clinical relationship of these gram negative bacteria and their resistance mechanisms in patients with diabetic foot and infected ulcer in India.

Methods: An observational study of 532 patients with infected ulcers in diabetic feet was conducted in Hycare for Wounds a tertiary care centre exclusively dedicated for Wound care and Management between May, 2017 and April, 2018. Processing and identification was done as per standard guidelines. The bacteriological assessment was performed in deep tissue cultures and amputation was considered major when performed above the foot’s middle tarsus.

Results: Out of 532 patients studied 350 were positive for bacterial growth. Commonest   isolate was Pseudomonas aeruginosa followed by Staphylococcus aureus (MSSA) species, Klebsiella and E. coli. We observed that 14 patients were infected with Acinetobacter baumannii and 50 % were carbapenamase producers.

Clinical Outcomes: Out of 14 patients 6 were major amputees and 5 were minor amputees and the rest 3 patients are under medical management.

Conclusion: Carbapenem-resistant Acinetobacter baumannii is a serious threat to Diabetic patients and can be considered as a risk factor for major amputation.

Downloads

Download data is not yet available.

References

IDF Diabetes Atlas, 8th Ed. Brussels, Belgium: International Diabetes

Federation, 2017.

http://www.diabetesatlas.org/resources/2017atlas.html. Accessed 29

October 2018.

Shanmugam P, Jeya M. The bacteriology of diabetic foot ulcers, with

a special reference to multidrug resistant strains. J Clin Diagn Res.

;7(3):441.

Smolyakov R, Borer A, Reisenberg K, Schlaeffer F, Alkan M, Porath

A, et al. Nosocomial multi-drug resistant Acinetobacter baumannii

blood stream infection: risk factors and outcome with ampicillinsulbactam treatment. J Hosp Infect 2003;54: 32-8.

L. Dent, D.R. Marshall, S. Pratap, R.B. Hulette.Multidrug resistant

Acinetobacter baumannii: a descriptive study in a city hospital.BMC

Infect. Dis., 10 (2010), p. 196.

Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer

AW, LeFrock JL, Lew DP, Mader JT, Norden C, Tan JS. Diagnosis

and treatment of diabetic foot infections. Clinical Infectious Diseases.

Oct 1;39(7):885-910.

Clinical and laboratory standards institute. Performance standards for

Antimicrobial susceptibility testing. M02 – A12, M07 – A10 and M11 –

A8. M100 S. 26th Edition.

Lipsky BA, Aragon-Sanchez J, Diggle M, Embil J, Kono S, Lavery L,

et al. International Working Group on the Diabetic Foot (IWGDF),

Peters EJ. IWGDF guidance on the diagnosis and management of foot

infections in persons with diabetes. Diabetes Metab Res Rev

;24(Suppl 1):45–74.

Sekhar S, Vyas N, Unnikrishnan M, Rodrigues G, Mukhopadhyay C.

Antimicrobial susceptibility pattern in diabetic foot ulcer: a pilot study.

Ann Med Health Sci Res. 2014; 4:742-5.

Shahi SK, Singh VK, Kumar A, Khan AU. Detection of Escherichia coli

and Associated β-Lactamases Genes from Diabetic Foot Ulcers by

Multiplex PCR and Molecular Modeling and Docking of SHV-1, TEM1, and OXA-1 β-Lactamases with Clindamycin and Piperacillin

Tazobactam. PLoS One. 2013;8(7):e68234.

Mills JL, Sr., Conte MS, Armstrong DG, Pomposelli FB, Schanzer A,

Sidawy AN, et al. The Society for Vascular Surgery Lower Extremity

Threatened Limb Classification System: risk stratification based on

wound, ischemia, and foot infection (WIfI). J Vasc Surg.

;59(1):220-34.e1-2.

Martins AF, Barth AL. Acinetobacter multi resistente - um desafio para

a saúde pública. Sci Med. 2013;23(1):56-62.

Karageorgopoulos DE, Falagas ME. Current control and treatment of

multidrug-resistant Acinetobacter baumannii infections. Lancet Infect

Dis. 2008;8(12):751–762.

Downloads

Published

26.03.2024

Issue

Section

ORIGINAL ARTICLES ~ General Surgery

Similar Articles

1-10 of 147

You may also start an advanced similarity search for this article.